共 45 条
[1]
Lippa C.F., Duda J.E., Grossman M., Et al., DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers, Neurology, 68, 11, pp. 812-819, (2007)
[2]
Vasconcellos L.F., Pereira J.S., Parkinson’s disease dementia: diagnostic criteria and risk factor review, J Clin Exp Neuropsychol, 37, 9, pp. 988-993, (2015)
[3]
McKeith I.G., Dickson D.W., Lowe J., Et al., Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium, Neurology, 65, pp. 1863-1872, (2005)
[4]
Hely M.A., Reid W.G., Adena M.A., Et al., The Sydney multicenter study of Parkinson’s disease: the inevitability of dementia at 20 years, Mov Disord, 23, 6, pp. 837-844, (2008)
[5]
Emre M., Aarsland D., Brown R., Et al., Clinical diagnostic criteria for dementia associated with Parkinson’s disease, Mov Disord, 22, pp. 1689-1707, (2007)
[6]
McKeith I., Dementia with Lewy bodies and Parkinson’s disease with dementia: where two worlds collide, Pract Neurol, 7, pp. 374-382, (2007)
[7]
Spillantini M.G., Schmidt M.L., Lee V.M., Et al., Alpha-synuclein in Lewy bodies, Nature, 388, pp. 839-840, (1997)
[8]
Surendranathan A., Rowe J.B., O'Brien J.T., Neuroinflammation in Lewy body dementia, Parkinsonism Relat Disord, 21, 12, pp. 1398-1406, (2015)
[9]
Francis P.T., Perry E.K., Cholinergic and other neurotransmitter mechanisms in Parkinson’s disease, Parkinson’s disease dementia, and dementia with Lewy bodies, Mov Disord, 22, pp. 351-357, (2007)
[10]
Biundo R., Weis L., Bostantjopoulou S., Et al., MMSE and MoCA in Parkinson’s disease and dementia with Lewy bodies: a multicenter 1-year follow-up study, J Neural Transm, 123, pp. 431-438, (2016)